Detalhe da pesquisa
1.
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
Gut;
72(3): 581-589, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36750244
2.
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.
Hepatology;
75(5): 1235-1246, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34662449
3.
Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.
Hepatology;
75(4): 968-982, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34662439
4.
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.
Liver Int;
43(1): 77-89, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36300646
5.
Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
Am J Gastroenterol;
117(3): 453-461, 2022 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35041626
6.
Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver Injury.
Hepatology;
74(6): 3394-3408, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34216018
7.
A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis.
Hepatology;
74(6): 3146-3160, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34333790
8.
Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015-March 2018.
Clin Infect Dis;
71(5): 1263-1268, 2020 08 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31563938
9.
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).
Hepatology;
70(4): 1336-1348, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30762895
10.
Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.
Hepatology;
69(2): 684-698, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30153359
11.
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials.
Hepatology;
70(6): 1913-1927, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30993748
12.
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.
Hepatology;
70(5): 1521-1530, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31271665
13.
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
J Hepatol;
70(1): 133-141, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30291868
14.
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
Gastroenterology;
154(8): 2111-2121.e8, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29535028
15.
Simtuzumab Is Ineffective for Patients With Bridging Fibrosis or Compensated Cirrhosis Caused by Nonalcoholic Steatohepatitis.
Gastroenterology;
155(4): 1140-1153, 2018 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29990488
16.
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial.
Hepatology;
67(2): 549-559, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28892558
17.
Safety and effectiveness of lusutrombopag in Japanese chronic liver disease patients with thrombocytopenia undergoing invasive procedures: Interim results of a postmarketing surveillance.
Hepatol Res;
49(10): 1169-1181, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31228221
18.
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
J Hepatol;
69(6): 1365-1370, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30144554
19.
Sofosbuvir and Ribavirin Liver Pharmacokinetics in Patients Infected with Hepatitis C Virus.
Antimicrob Agents Chemother;
62(5)2018 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29439971
20.
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
N Engl J Med;
373(27): 2608-17, 2015 Dec 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26575258